Cronos Group (CRON)
(Delayed Data from NSDQ)
$2.32 USD
+0.10 (4.50%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $2.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CRON 2.32 +0.10(4.50%)
Will CRON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRON
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Lags Revenue Estimates
Cronos Group (CRON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CRON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains?
3 Cannabis Stocks Soaring on HHS' Recommendation to DEA
Pacira (PCRX) Lags Q2 Earnings and Revenue Estimates
Other News for CRON
CRON Stock Earnings: Cronos Group Beats Revenue for Q2 2024
Cronos Group Inc. (CRON) Q2 2024 Earnings Call Transcript
Rising High: Exclusive talk with cannabis marketplace Weedmaps
Highest On Record - Cronos Group Reports 46% YoY Increase In Q2 Net Revenue
Cronos: Q2 Earnings Snapshot